Estrov Z - Search Results

1

Salvage therapy using FLT3 inhibitors may improve long-term outcome of relapsed or refractory AML in patients with FLT3-ITD.

Takahashi K, Kantarjian H, Pemmaraju N, Andreeff M, Borthakur G, Faderl S, Garcia-Manero G, Pierce S, Luthra R, Cardenas-Turanzas M, Estrov Z, Ravandi F, Cortes J. Takahashi K, et al. Among authors: estrov z. Br J Haematol. 2013 Jun;161(5):659-666. doi: 10.1111/bjh.12299. Epub 2013 Mar 27. Br J Haematol. 2013. PMID: 23530930 Free PMC article.

2

Comparison of in vivo and in vitro effects of granulocyte-macrophage colony-stimulating factor (GM-CSF) in patients with acute myeloid leukemia.

Estrov Z, Estey EH, Andreeff M, Talpaz M, Kurzrock R, Reading CL, Deisseroth AB, Gutterman JU. Estrov Z, et al. Exp Hematol. 1992 Jun;20(5):558-64. Exp Hematol. 1992. PMID: 1587302

3

Suppression of chronic myelogenous leukemia colony growth by interleukin-1 (IL-1) receptor antagonist and soluble IL-1 receptors: a novel application for inhibitors of IL-1 activity.

Estrov Z, Kurzrock R, Wetzler M, Kantarjian H, Blake M, Harris D, Gutterman JU, Talpaz M. Estrov Z, et al. Blood. 1991 Sep 15;78(6):1476-84. Blood. 1991. PMID: 1715791 Free article.

4

Granulocyte-colony stimulating factor, granulocyte-macrophage colony stimulating factor, PIXY-321, stem cell factor, interleukin-3, and interleukin-7: receptor binding and effects on clonogenic proliferation in acute lymphoblastic leukemia.

Drach D, Estrov Z, Zhao S, Drach J, Cork A, Collins D, Kantarjian H, Andreeff M. Drach D, et al. Among authors: estrov z. Leuk Lymphoma. 1994 Dec;16(1-2):79-88. doi: 10.3109/10428199409114143. Leuk Lymphoma. 1994. PMID: 7535143

5

Persistence of dormant leukemic progenitors during interferon-induced remission in chronic myelogenous leukemia. Analysis by polymerase chain reaction of individual colonies.

Talpaz M, Estrov Z, Kantarjian H, Ku S, Foteh A, Kurzrock R. Talpaz M, et al. Among authors: estrov z. J Clin Invest. 1994 Oct;94(4):1383-9. doi: 10.1172/JCI117473. J Clin Invest. 1994. PMID: 7929813 Free PMC article.

6

Altered levels of interleukin-1 beta and interleukin-1 receptor antagonist in chronic myelogenous leukemia: clinical and prognostic correlates.

Wetzler M, Kurzrock R, Estrov Z, Kantarjian H, Gisslinger H, Underbrink MP, Talpaz M. Wetzler M, et al. Among authors: estrov z. Blood. 1994 Nov 1;84(9):3142-7. Blood. 1994. PMID: 7949186 Free article. Clinical Trial.

7

Heterogeneity in lineage derivation of Philadelphia-positive acute lymphoblastic leukemia expressing p190BCR-ABL or p210BCR-ABL: determination by analysis of individual colonies with the polymerase chain reaction.

Estrov Z, Talpaz M, Kantarjian HM, Zipf TF, McClain KL, Kurzrock R. Estrov Z, et al. Cancer Res. 1993 Jul 15;53(14):3289-93. Cancer Res. 1993. PMID: 8324740

8

Chronic myelogenous leukemia: a concise update.

Kantarjian HM, Deisseroth A, Kurzrock R, Estrov Z, Talpaz M. Kantarjian HM, et al. Among authors: estrov z. Blood. 1993 Aug 1;82(3):691-703. Blood. 1993. PMID: 8338938 Free article. Review. No abstract available.

9

Lymphotoxin is an autocrine growth factor for Epstein-Barr virus-infected B cell lines.

Estrov Z, Kurzrock R, Pocsik E, Pathak S, Kantarjian HM, Zipf TF, Harris D, Talpaz M, Aggarwal BB. Estrov Z, et al. J Exp Med. 1993 Mar 1;177(3):763-74. doi: 10.1084/jem.177.3.763. J Exp Med. 1993. PMID: 8382256 Free PMC article.

10

Ubiquitous expression of cytokines in diverse leukemias of lymphoid and myeloid lineage.

Kurzrock R, Kantarjian H, Wetzler M, Estrov Z, Estey E, Troutman-Worden K, Gutterman JU, Talpaz M. Kurzrock R, et al. Among authors: estrov z. Exp Hematol. 1993 Jan;21(1):80-5. Exp Hematol. 1993. PMID: 8417962

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

506 results

Search Page

Filters